Last Updated: May 10, 2026

Suppliers and packagers for PIVYA


✉ Email this page to a colleague

« Back to Dashboard


PIVYA

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Alembic Therap PIVYA pivmecillinam hydrochloride TABLET;ORAL 216483 NDA Alembic Pharmaceuticals Inc. 62332-966-09 1 BLISTER PACK in 1 CARTON (62332-966-09) / 9 TABLET, COATED in 1 BLISTER PACK 2026-02-02
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Who Supplies “Pivya” (Pivya Drug) and What’s Known?

Last updated: April 23, 2026

Which companies supply Pivya?

No supplier or manufacturer information can be produced from the information provided. “Pivya” is an insufficiently specific drug identifier to map to a single marketed product, active ingredient, strength, dosage form, and regulatory dossier that would support supplier attribution.

What dosing/formulation details are needed to identify suppliers?

No dosing regimen, dosage form, strength, route of administration, or regional brand context (US, EU, UK, India, etc.) is provided for “Pivya,” so supplier mapping cannot be completed.

What sources would normally be used to build a supplier list?

A complete supplier list for a pharmaceutical brand typically requires at least one of the following to anchor the product identity and supply chain:

  • Market authorization dossier identifiers (e.g., EMA EPAR product page, US NDA/BLA label)
  • Labelled manufacturer and packager of record sections
  • Regulatory drug registration entries by country
  • Patent and trademark filings that tie the brand name to an applicant and drug substance/formulation

Because none of those product-identifying facts are available in the prompt, a supplier list would be non-actionable.

Supply chain deliverables (what a supplier list would include)

A decision-grade supplier map normally includes:

  • Marketing authorization holder (MAH)
  • Finished dosage manufacturer (drug product)
  • Batch release testing site (if disclosed)
  • Primary contract manufacturing organizations (CMOs) for formulation/filled units
  • Drug substance (API) manufacturers (if disclosed)
  • Packaging site (if disclosed)

No such specifics can be attributed to “Pivya” from the prompt alone.

Key Takeaways

  • A supplier list for “Pivya” cannot be generated from the provided input.
  • “Pivya” alone is not enough to reliably identify the marketed product and its listed manufacturers.
  • Supplier attribution requires product identity (active ingredient, strength, dosage form, and market).

FAQs

  1. Is “Pivya” a generic or brand name?
    The prompt does not specify, so the supply-chain identity cannot be determined.

  2. Can I list suppliers by searching “Pivya” alone?
    Supplier attribution requires the exact product identity; brand-name matches alone can point to different actives and formulations.

  3. What supplier roles matter for diligence?
    MAH, drug product manufacturer, and API supplier roles are the core items used in investment and R&D diligence.

  4. Do regulators publish supplier names for all markets?
    They often do, but only when the product identity is unambiguous and tied to a specific authorization.

  5. Can patent applicants substitute for suppliers?
    Patent applicants can suggest upstream ownership, but they do not reliably equal manufacturing supply-chain vendors without corroborating label or regulatory entries.

References

No sources are cited because no product-identifying information was provided.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.